⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KZR News
Kezar Life Sciences, Inc. Common Stock
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
businesswire.com
KZR
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
businesswire.com
KZR
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
businesswire.com
KZR